The Safety and the Efficacy of Maintenance Therapy of Recombinant Human Erythropoietin in Patients With Renal Insufficiency

This publication has 8 references indexed in Scilit:

• The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
  Kidney International, 1989
• SUBCUTANEOUS ERYTHROPOIETIN
  The Lancet, 1988
• Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass.
  Proceedings of the National Academy of Sciences, 1988
• Effect of recombinant human erythropoietin on the anemia of chronic renal failure
  The International Journal of Cell Cloning, 1988
• Inhibition by interleukin-1 of the action of erythropoietin on erythroid precursors and its possible role in the pathogenesis of hypoplastic anaemias
  British Journal of Haematology, 1987
• Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
  New England Journal of Medicine, 1987
• EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSIS
  The Lancet, 1986
• Erythropoiesis in Patients with Renal Failure Undergoing Chronic Dialysis
  New England Journal of Medicine, 1967